[Cochlear implant and tinnitus].
Cochlear implant (CI) treatment is now established as a successful standard of care for auditory rehabilitation of profoundly deaf or severe hearing loss patients. CI candidates with tinnitus also ben...
Maladies virales : Questions médicales fréquentes
Questions fréquentes et termes MeSH associés
Diagnostic 5
#1
Comment diagnostique-t-on une infection virale ?
Le diagnostic repose sur des tests sanguins, des cultures virales et des analyses cliniques.
#2
Quels tests sont utilisés pour le VIH ?
Les tests de dépistage incluent les tests ELISA et les tests de charge virale.
#3
Les symptômes peuvent-ils indiquer un virus spécifique ?
Oui, certains symptômes comme la fièvre ou la toux peuvent orienter vers un virus particulier.
#4
Quelle est l'importance des tests PCR ?
Les tests PCR détectent l'ADN ou l'ARN viral, permettant un diagnostic précoce et précis.
#5
Peut-on diagnostiquer une grippe sans test ?
Oui, un médecin peut diagnostiquer la grippe par l'examen clinique et les symptômes.
Symptômes 5
#1
Quels sont les symptômes courants des maladies virales ?
Fièvre, fatigue, douleurs musculaires, toux et maux de tête sont fréquents.
#2
La diarrhée est-elle un symptôme viral ?
Oui, certaines infections virales, comme le rotavirus, peuvent provoquer des diarrhées.
#3
Les éruptions cutanées sont-elles liées aux virus ?
Oui, des virus comme la varicelle peuvent provoquer des éruptions cutanées.
#4
Comment la fatigue se manifeste-t-elle dans les infections virales ?
La fatigue peut être intense et persistante, souvent due à la réponse immunitaire.
#5
Les symptômes varient-ils selon le virus ?
Oui, chaque virus peut provoquer un ensemble de symptômes distincts.
Prévention 5
#1
Comment prévenir les infections virales ?
Se laver les mains, éviter les contacts étroits et se faire vacciner sont essentiels.
#2
Les vaccins sont-ils sûrs ?
Oui, les vaccins sont rigoureusement testés pour leur sécurité et leur efficacité.
#3
Le port du masque aide-t-il à prévenir les virus ?
Oui, le port du masque réduit la transmission des virus respiratoires.
#4
Quelles sont les recommandations pour les voyages ?
Se faire vacciner et éviter les foules sont recommandés lors de voyages.
#5
L'hygiène alimentaire peut-elle prévenir les infections ?
Oui, une bonne hygiène alimentaire réduit le risque d'infections virales d'origine alimentaire.
Traitements 5
#1
Quels traitements sont disponibles pour les infections virales ?
Les traitements incluent des antiviraux, des soins symptomatiques et des vaccins.
#2
Les antibiotiques sont-ils efficaces contre les virus ?
Non, les antibiotiques ne traitent que les infections bactériennes, pas virales.
#3
Comment les antiviraux fonctionnent-ils ?
Les antiviraux inhibent la réplication virale, réduisant la gravité et la durée de l'infection.
#4
Les vaccins préviennent-ils les maladies virales ?
Oui, les vaccins stimulent le système immunitaire pour prévenir certaines infections virales.
#5
Quels sont les traitements pour l'hépatite virale ?
Les traitements incluent des antiviraux spécifiques et des soins de soutien.
Complications 5
#1
Quelles complications peuvent survenir avec la grippe ?
Des complications comme la pneumonie et l'aggravation des maladies chroniques peuvent survenir.
#2
Les infections virales peuvent-elles causer des maladies chroniques ?
Oui, certaines infections virales peuvent entraîner des maladies chroniques comme l'hépatite.
#3
Quelles sont les complications du VIH ?
Le VIH peut entraîner des infections opportunistes et des cancers liés à l'immunodéficience.
#4
Les virus peuvent-ils affecter le système nerveux ?
Oui, des virus comme le virus de la rage peuvent causer des atteintes neurologiques graves.
#5
Quelles complications peuvent survenir après une infection par le COVID-19 ?
Des complications comme le syndrome post-COVID, des problèmes respiratoires et neurologiques peuvent survenir.
Facteurs de risque 5
#1
Quels sont les facteurs de risque pour les infections virales ?
Les facteurs incluent un système immunitaire affaibli, le vieillissement et le manque de vaccination.
#2
Le stress augmente-t-il le risque d'infections virales ?
Oui, le stress peut affaiblir le système immunitaire, augmentant le risque d'infections.
#3
Les enfants sont-ils plus à risque d'infections virales ?
Oui, les enfants ont un système immunitaire en développement, les rendant plus vulnérables.
#4
Le tabagisme influence-t-il les infections virales ?
Oui, le tabagisme peut affaiblir les défenses immunitaires et augmenter le risque d'infections.
#5
Les voyages augmentent-ils le risque d'infections virales ?
Oui, les voyages peuvent exposer à de nouveaux virus et augmenter le risque d'infection.
Contenu validé par Dr Olivier Menir
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 26/04/2025
Contenu vérifié selon les dernières recommandations médicales
Sous-catégories
83 au total
└─
Infections à arbovirus
Arbovirus InfectionsD001102 -
C01.925.081
└─
Infections à virus à ADN
DNA Virus InfectionsD004266 -
C01.925.256
└─
Infections à virus à ARN
RNA Virus InfectionsD012327 -
C01.925.782
└─
Infections à virus lents
Slow Virus DiseasesD012897 -
C01.925.839
└─
Infections à virus oncogènes
Tumor Virus InfectionsD014412 -
C01.925.928
└─└─
Infections à Adenoviridae
Adenoviridae InfectionsD000257 -
C01.925.256.076
└─└─
Infections à Circoviridae
Circoviridae InfectionsD018173 -
C01.925.256.200
└─└─
Infections à Hepadnaviridae
Hepadnaviridae InfectionsD018347 -
C01.925.256.430
└─└─
Infections à Herpesviridae
Herpesviridae InfectionsD006566 -
C01.925.256.466
└─└─
Infections à Parvoviridae
Parvoviridae InfectionsD010322 -
C01.925.256.700
└─└─
Infections à polyomavirus
Polyomavirus InfectionsD027601 -
C01.925.256.721
└─└─
Infections à Poxviridae
Poxviridae InfectionsD011213 -
C01.925.256.743
└─└─
Infections à Arenaviridae
Arenaviridae InfectionsD001117 -
C01.925.782.082
└─└─
Infections à Astroviridae
Astroviridae InfectionsD019350 -
C01.925.782.105
└─└─
Infections à Birnaviridae
Birnaviridae InfectionsD018175 -
C01.925.782.123
└─└─
Infections à Bunyaviridae
Bunyaviridae InfectionsD002044 -
C01.925.782.147
└─└─
Infections à Caliciviridae
Caliciviridae InfectionsD017250 -
C01.925.782.160
└─└─
Infections à Flaviviridae
Flaviviridae InfectionsD018178 -
C01.925.782.350
└─└─
Fièvres hémorragiques virales
Hemorrhagic Fevers, ViralD006482 -
C01.925.782.417
└─└─
Infections à Mononegavirales
Mononegavirales InfectionsD018701 -
C01.925.782.580
└─└─
Infections à Nidovirales
Nidovirales InfectionsD030341 -
C01.925.782.600
└─└─
Infections à Orthomyxoviridae
Orthomyxoviridae InfectionsD009976 -
C01.925.782.620
└─└─
Infections à Picornaviridae
Picornaviridae InfectionsD010850 -
C01.925.782.687
└─└─
Infections à Reoviridae
Reoviridae InfectionsD012088 -
C01.925.782.791
└─└─
Infections à Retroviridae
Retroviridae InfectionsD012192 -
C01.925.782.815
└─└─
Infections à Togaviridae
Togaviridae InfectionsD014036 -
C01.925.782.930
└─└─
Infections à virus Epstein-Barr
Epstein-Barr Virus InfectionsD020031 -
C01.925.928.313
└─└─└─
Infections humaines à adénovirus
Adenovirus Infections, HumanD000258 -
C01.925.256.076.045
└─└─└─
Infections à cytomégalovirus
Cytomegalovirus InfectionsD003586 -
C01.925.256.466.245
└─└─└─
Infections à roséolovirus
Roseolovirus InfectionsD019349 -
C01.925.256.466.850
└─└─└─
Infection à virus varicelle-zona
Varicella Zoster Virus InfectionD000073618 -
C01.925.256.466.930
└─└─└─
Cowpox
CowpoxD015605 -
C01.925.256.743.175
└─└─└─
Variole
SmallpoxD012899 -
C01.925.256.743.826
└─└─└─
Vaccine
VacciniaD014615 -
C01.925.256.743.929
└─└─└─
Infections à hantavirus
Hantavirus InfectionsD018778 -
C01.925.782.147.420
└─└─└─
Fièvre à phlébotomes
Phlebotomus FeverD010217 -
C01.925.782.147.700
└─└─└─
Syndrome de fièvre sévère avec thrombocytopénie
Severe Fever with Thrombocytopenia SyndromeD000085142 -
C01.925.782.147.905
└─└─└─
Infections à flavivirus
Flavivirus InfectionsD018177 -
C01.925.782.350.250
└─└─└─
Infections à pestivirus
Pestivirus InfectionsD018182 -
C01.925.782.350.675
└─└─└─
Dengue
DengueD003715 -
C01.925.782.417.214
└─└─└─
Fièvre hémorragique avec syndrome rénal
Hemorrhagic Fever with Renal SyndromeD006480 -
C01.925.782.417.300
└─└─└─
Fièvre hémorragique américaine
Hemorrhagic Fever, AmericanD006478 -
C01.925.782.417.400
└─└─└─
Fièvre hémorragique de Crimée-Congo
Hemorrhagic Fever, CrimeanD006479 -
C01.925.782.417.412
└─└─└─
Fièvre hémorragique d'Omsk
Hemorrhagic Fever, OmskD006481 -
C01.925.782.417.435
└─└─└─
Maladie de la forêt Kyasanur
Kyasanur Forest DiseaseD007733 -
C01.925.782.417.475
└─└─└─
Fièvre de Lassa
Lassa FeverD007835 -
C01.925.782.417.505
└─└─└─
Fièvre jaune
Yellow FeverD015004 -
C01.925.782.417.881
└─└─└─
Infections à Filoviridae
Filoviridae InfectionsD018702 -
C01.925.782.580.250
└─└─└─
Infections à Paramyxoviridae
Paramyxoviridae InfectionsD018184 -
C01.925.782.580.600
└─└─└─
Infections à Rhabdoviridae
Rhabdoviridae InfectionsD018353 -
C01.925.782.580.830
└─└─└─
Infections à artérivirus
Arterivirus InfectionsD018174 -
C01.925.782.600.100
└─└─└─
Infections à Coronaviridae
Coronaviridae InfectionsD003333 -
C01.925.782.600.550
└─└─└─
Infections à cardiovirus
Cardiovirus InfectionsD018188 -
C01.925.782.687.150
└─└─└─
Infections à entérovirus
Enterovirus InfectionsD004769 -
C01.925.782.687.359
└─└─└─
Fièvre à tiques du Colorado
Colorado Tick FeverD003121 -
C01.925.782.791.482
└─└─└─
Infections à rotavirus
Rotavirus InfectionsD012400 -
C01.925.782.791.814
└─└─└─
Infections à lentivirus
Lentivirus InfectionsD016180 -
C01.925.782.815.616
└─└─└─
Infections à alphavirus
Alphavirus InfectionsD018354 -
C01.925.782.930.100
└─└─└─
Infections à rubivirus
Rubivirus InfectionsD018355 -
C01.925.782.930.700
└─└─└─└─
Varicelle
ChickenpoxD002644 -
C01.925.256.466.930.250
└─└─└─└─
Zona
Herpes ZosterD006562 -
C01.925.256.466.930.750
└─└─└─└─
Infection par le virus Zika
Zika Virus InfectionD000071243 -
C01.925.782.350.250.990
└─└─└─└─
Dengue sévère
Severe DengueD019595 -
C01.925.782.417.214.200
└─└─└─└─
Fièvre hémorragique à virus Ebola
Hemorrhagic Fever, EbolaD019142 -
C01.925.782.580.250.400
└─└─└─└─
Infections à avulavirus
Avulavirus InfectionsD045463 -
C01.925.782.580.600.080
└─└─└─└─
Infections à hénipavirus
Henipavirus InfectionsD045464 -
C01.925.782.580.600.400
└─└─└─└─
Infections à virus morbilleux
Morbillivirus InfectionsD018185 -
C01.925.782.580.600.500
└─└─└─└─
Infections à pneumovirus
Pneumovirus InfectionsD018186 -
C01.925.782.580.600.550
└─└─└─└─
Infections à respirovirus
Respirovirus InfectionsD010253 -
C01.925.782.580.600.600
└─└─└─└─
Infections à rubulavirus
Rubulavirus InfectionsD019351 -
C01.925.782.580.600.680
└─└─└─└─
Rage (maladie)
RabiesD011818 -
C01.925.782.580.830.750
└─└─└─└─
Infections à coronavirus
Coronavirus InfectionsD018352 -
C01.925.782.600.550.200
└─└─└─└─
Infections à torovirus
Torovirus InfectionsD018176 -
C01.925.782.600.550.800
└─└─└─└─
Infections à virus coxsackie
Coxsackievirus InfectionsD003384 -
C01.925.782.687.359.213
└─└─└─└─
Infections à échovirus
Echovirus InfectionsD004457 -
C01.925.782.687.359.347
└─└─└─└─
Fièvre chikungunya
Chikungunya FeverD065632 -
C01.925.782.930.100.184
└─└─└─└─
Rubéole
RubellaD012409 -
C01.925.782.930.700.700
└─└─└─└─└─
Zona sine herpete
Zoster Sine HerpeteD031368 -
C01.925.256.466.930.750.970
└─└─└─└─└─
Rougeole
MeaslesD008457 -
C01.925.782.580.600.500.500
└─└─└─└─└─
Infections à virus respiratoire syncytial
Respiratory Syncytial Virus InfectionsD018357 -
C01.925.782.580.600.550.750
└─└─└─└─└─
Syndrome mains-pieds-bouche
Hand, Foot and Mouth DiseaseD006232 -
C01.925.782.687.359.213.331
└─└─└─└─└─
Pleurodynie épidémique
Pleurodynia, EpidemicD011000 -
C01.925.782.687.359.213.737
└─└─└─└─└─
Herpangine
HerpanginaD006557 -
C01.925.782.687.359.347.500
Auteurs principaux
Benedikt B Kaufer
3 publications dans cette catégorie
Affiliations :
- Institut für Virologie, Zentrum für Infektionsmedizin, Freie Universität Berlin, Berlin, Germany.
Publications dans "Maladies virales" :
-
The Marek's Disease Virus Unique Gene MDV082 Is Dispensable for Virus Replication but Contributes to a Rapid Disease Onset.
Journal of virology 2021-07-12
-
The Role of Marek's Disease Virus UL12 and UL29 in DNA Recombination and the Virus Lifecycle.
Viruses 2019-01-28
-
Replication of Marek's Disease Virus Is Dependent on Synthesis of
Journal of virology 2019-06-14
Ian Crozier
2 publications dans cette catégorie
Affiliations :
- Integrated Research Facility at Fort Detrick, Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research supported by the National Cancer Institute, Frederick, MD, USA.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
-
Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease.
The New England journal of medicine
Nicole M Nemeth
2 publications dans cette catégorie
Affiliations :
- Southeastern Cooperative Wildlife Disease Study, University of Georgia, 589 D.W. Brooks Drive, Athens, Georgia 30602, USA.
- Department of Pathology, University of Georgia, 501 D.W. Brooks Drive, Athens, Georgia 30602, USA.
Publications dans "Maladies virales" :
-
Lymphoproliferative Disease Virus and Reticuloendotheliosis Virus Detection and Disease in Wild Turkeys (Meleagris gallopavo).
Journal of wildlife diseases 2023-11-16
-
Lymphoproliferative Disease Virus in Wild Turkeys (
Avian diseases
Yu You
2 publications dans cette catégorie
Affiliations :
- Institut für Virologie, Zentrum für Infektionsmedizin, Freie Universität Berlin, Berlin, Germany.
Publications dans "Maladies virales" :
Luca D Bertzbach
2 publications dans cette catégorie
Affiliations :
- Institut für Virologie, Zentrum für Infektionsmedizin, Freie Universität Berlin, Berlin, Germany.
- Leibniz Institut für Experimentelle Virologie (HPI), Forschungsabteilung Virale Transformation, Hamburg, Germany.
Publications dans "Maladies virales" :
Bairong Shen
2 publications dans cette catégorie
Affiliations :
- Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China. bairong.shen@scu.edu.cn.
Publications dans "Maladies virales" :
-
Predicting the Disease Severity of Virus Infection.
Advances in experimental medicine and biology
-
In Silico Drug Discovery for Treatment of Virus Diseases.
Advances in experimental medicine and biology
Van T Tong
2 publications dans cette catégorie
Affiliations :
- From Instituto Nacional de Salud (M.L.O., M.G., M.M., A.J.R, A.R., L.P., G.A., S.G., F.P., O.P.), Bogota, Colombia; and the Centers for Disease Control and Prevention (V.T.T., D.V., S.M.G., S.C.T., C.M.W., J.D.T., J.M.V., D.M.D., M.A.H.) and the Department of Gynecology and Obstetrics, Emory University School of Medicine (D.J.J.), Atlanta.
Publications dans "Maladies virales" :
-
Zika Virus Disease and Pregnancy Outcomes in Colombia.
The New England journal of medicine
-
Zika Virus Disease in Colombia - Preliminary Report.
The New England journal of medicine 2016-06-15
Diana Valencia
2 publications dans cette catégorie
Affiliations :
- From Instituto Nacional de Salud (M.L.O., M.G., M.M., A.J.R, A.R., L.P., G.A., S.G., F.P., O.P.), Bogota, Colombia; and the Centers for Disease Control and Prevention (V.T.T., D.V., S.M.G., S.C.T., C.M.W., J.D.T., J.M.V., D.M.D., M.A.H.) and the Department of Gynecology and Obstetrics, Emory University School of Medicine (D.J.J.), Atlanta.
Publications dans "Maladies virales" :
-
Zika Virus Disease and Pregnancy Outcomes in Colombia.
The New England journal of medicine
-
Zika Virus Disease in Colombia - Preliminary Report.
The New England journal of medicine 2016-06-15
Marcela Mercado
2 publications dans cette catégorie
Affiliations :
- From Instituto Nacional de Salud (M.L.O., M.G., M.M., A.J.R, A.R., L.P., G.A., S.G., F.P., O.P.), Bogota, Colombia; and the Centers for Disease Control and Prevention (V.T.T., D.V., S.M.G., S.C.T., C.M.W., J.D.T., J.M.V., D.M.D., M.A.H.) and the Department of Gynecology and Obstetrics, Emory University School of Medicine (D.J.J.), Atlanta.
Publications dans "Maladies virales" :
-
Zika Virus Disease and Pregnancy Outcomes in Colombia.
The New England journal of medicine
-
Zika Virus Disease in Colombia - Preliminary Report.
The New England journal of medicine 2016-06-15
Lissethe Pardo
2 publications dans cette catégorie
Affiliations :
- From Instituto Nacional de Salud (M.L.O., M.G., M.M., A.J.R, A.R., L.P., G.A., S.G., F.P., O.P.), Bogota, Colombia; and the Centers for Disease Control and Prevention (V.T.T., D.V., S.M.G., S.C.T., C.M.W., J.D.T., J.M.V., D.M.D., M.A.H.) and the Department of Gynecology and Obstetrics, Emory University School of Medicine (D.J.J.), Atlanta.
Publications dans "Maladies virales" :
-
Zika Virus Disease and Pregnancy Outcomes in Colombia.
The New England journal of medicine
-
Zika Virus Disease in Colombia - Preliminary Report.
The New England journal of medicine 2016-06-15
Denise J Jamieson
2 publications dans cette catégorie
Affiliations :
- From Instituto Nacional de Salud (M.L.O., M.G., M.M., A.J.R, A.R., L.P., G.A., S.G., F.P., O.P.), Bogota, Colombia; and the Centers for Disease Control and Prevention (V.T.T., D.V., S.M.G., S.C.T., C.M.W., J.D.T., J.M.V., D.M.D., M.A.H.) and the Department of Gynecology and Obstetrics, Emory University School of Medicine (D.J.J.), Atlanta.
Publications dans "Maladies virales" :
-
Zika Virus Disease and Pregnancy Outcomes in Colombia.
The New England journal of medicine
-
Zika Virus Disease in Colombia - Preliminary Report.
The New England journal of medicine 2016-06-15
Oscar Pacheco
2 publications dans cette catégorie
Affiliations :
- From Instituto Nacional de Salud (M.L.O., M.G., M.M., A.J.R, A.R., L.P., G.A., S.G., F.P., O.P.), Bogota, Colombia; and the Centers for Disease Control and Prevention (V.T.T., D.V., S.M.G., S.C.T., C.M.W., J.D.T., J.M.V., D.M.D., M.A.H.) and the Department of Gynecology and Obstetrics, Emory University School of Medicine (D.J.J.), Atlanta.
Publications dans "Maladies virales" :
-
Zika Virus Disease and Pregnancy Outcomes in Colombia.
The New England journal of medicine
-
Zika Virus Disease in Colombia - Preliminary Report.
The New England journal of medicine 2016-06-15
Margaret A Honein
2 publications dans cette catégorie
Affiliations :
- From Instituto Nacional de Salud (M.L.O., M.G., M.M., A.J.R, A.R., L.P., G.A., S.G., F.P., O.P.), Bogota, Colombia; and the Centers for Disease Control and Prevention (V.T.T., D.V., S.M.G., S.C.T., C.M.W., J.D.T., J.M.V., D.M.D., M.A.H.) and the Department of Gynecology and Obstetrics, Emory University School of Medicine (D.J.J.), Atlanta.
Publications dans "Maladies virales" :
-
Zika Virus Disease and Pregnancy Outcomes in Colombia.
The New England journal of medicine
-
Zika Virus Disease in Colombia - Preliminary Report.
The New England journal of medicine 2016-06-15
Shevin T Jacob
1 publication dans cette catégorie
Affiliations :
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
- Global Health Security Department, Infectious Diseases Institute, Makerere University, Kampala, Uganda.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
William A Fischer
1 publication dans cette catégorie
Affiliations :
- Department of Medicine, Division of Pulmonary Disease and Critical Care Medicine, Chapel Hill, NC, USA.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
Angela Hewlett
1 publication dans cette catégorie
Affiliations :
- Nebraska Biocontainment Unit, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
Colleen S Kraft
1 publication dans cette catégorie
Affiliations :
- Microbiology Section, Emory Medical Laboratory, Emory University School of Medicine, Atlanta, GA, USA.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
Marc-Antoine de La Vega
1 publication dans cette catégorie
Affiliations :
- Department of Microbiology, Immunology & Infectious Diseases, Université Laval, Quebec City, QC, Canada.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
Moses J Soka
1 publication dans cette catégorie
Affiliations :
- Partnership for Ebola Virus Disease Research in Liberia, Monrovia Medical Units ELWA-2 Hospital, Monrovia, Liberia.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
Victoria Wahl
1 publication dans cette catégorie
Affiliations :
- National Biodefense Analysis and Countermeasures Center, Fort Detrick, Frederick, MD, USA.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
Sources (10000 au total)
The hidden cochlear implant.
The hidden cochlear implant concept has two data transmission methods: Bluetooth low energy and transtympanic optical data transfer systems. This study aimed to present the hidden cochlear implant and... The Bluetooth low energy module was implanted into the implant bed. For the transtympanic optical data transfer tests, a receiver was passed through the posterior tympanotomy, and the transmitter was ... The Bluetooth low energy module range was 5.2-17.5 m. Transtympanic optical data transfer reached a rate of 1 Mbit/s and had 99.22 per cent accuracy. Despite various obstacles, the accuracy of the tra... Bluetooth low energy is suitable to be used transcutaneously. Transtympanic optical data transfer is an effective and promising technology. Hidden use cochlear implants aim to have the aesthetics of a...
Determinants of Cochlear Implant Satisfaction and Decisional Regret in Adult Cochlear Implant Users.
Determine associations expected and actual cochlear implant (CI) outcomes, decisional regret, and satisfaction in experienced adult CI users.... Cross-sectional cohort study.... Tertiary medical center.... Thirty-nine adult CI users meeting traditional bilateral hearing loss indications with ≥12 months CI experience.... Patients completed the validated Satisfaction with Amplification in Daily Living and Decisional Regret instruments. Pre- and post-CI outcomes (CI Quality of Life [CIQOL]-Expectations; CIQOL-35 Profile... Using established cutoff scores, 29% of patients reported a substantial degree of post-CI decisional regret. For each CIQOL domain, patients without decisional regret obtained post-CI outcome scores c... Patients with better alignment of their pre-CI expectations and post-CI outcomes and greater pre-/post-CIQOL improvement had lower decisional regret and higher satisfaction. This emphasizes the import...
The effect of cochlear implant age and duration of intervention on ESRT in children with cochlear implant.
To study the effect of cochlear implant age and duration of the intervention (auditory rehabilitation post-cochlear implantation) on ESRT in children with cochlear implants.... A total of 90 pre-lingual cochlear implant users were included. For the measurement of ESRTs the recipient's processor was connected to the programming pod and electrode numbers 22, 11 and 3 (apical, ... There were significant differences in the measured T, C and ESRT levels with respect to the duration of the intervention (auditory rehabilitation post-cochlear implantation) and cochlear implant age o... The differences in the T, C and ESRT levels after continued device usage and after attending auditory rehabilitation sessions post-cochlear implantation are subjected to optimal benefit from implantat... The differences in T, C and ESRT levels can be utilised clinically to study the importance of duration of cochlear implant device usage and the importance of auditory rehabilitation post-cochlear impl...
Development of an Optimized Protocol for Cochlear Implant Care to Increase Cochlear Implant Access.
To develop an evidence-based protocol for audiology-based, cochlear implant (CI) programming in the first year after activation.... Retrospective case review.... CI program at a tertiary medical center.... One-hundred seventy-one patients (178 ears; mean age at implantation, 62.3 yr; 44.4% female) implanted between 2016 and 2021 with postlingual onset of deafness and no history of CI revision surgery. P... Consonant-nucleus-consonant monosyllabic word recognition scores in the CI-alone and bilateral best-aided conditions at five time points: preoperative evaluation, and 1, 3, 6, and 12 months after acti... For both the CI-alone and bilateral best-aided conditions, consonant-nucleus-consonant word recognition significantly improved from preoperative evaluation to all postactivation time points. For the C... Based on the current data set and associated analyses, CI centers programming adult patients could eliminate either the 3- or 6-month visit from their clinical follow-up schedule if patient mapping of...
The remaining obstacles for a totally implantable cochlear implant.
For years, the development of a totally implantable cochlear implant (TICI) has faced several technical challenges hindering any prototypes from reaching full commercialization. This article aims to r... The literature review highlights how research efforts to generate sufficient power to supply a fully implantable CI could take advantage of microelectromechanical systems (MEMS)-based energy harvester... Recent breakthroughs in power supply using MEMS-based energy harvesting technologies and piezoelectric implantable microphones may make TICIs become a more practical reality in the foreseeable future....
Cochlear implant in tinnitus management.
To evaluate whether cochlear implantation can mitigate tinnitus perception and its discomfort among patients with severe-to-profound hearing loss, in order to provide an answer on a possible treatment... Tinnitus can develop after peripheral hearing loss and is associated with altered auditory processing. It does not only involve auditory structures but also aberrant neural activity and interaction wi... Recent studies investigated the changes in tinnitus perception among patients who underwent cochlear implantation and demonstrated a postoperative decrease. Hence, patients with severe-to-profound sen...
Monopolar Electrosurgery With Cochlear Implants.
To evaluate safety of monopolar electrosurgery (MES) in patients with cochlear implants (CIs) by reporting outcomes of a series of patients who underwent MES after CI.... Retrospective case series.... Tertiary referral center.... Patients with indwelling CI subsequently undergoing surgery with operative note specifically detailing MES use.... Adverse outcomes in post-operative audiology/otolaryngology documentation; speech recognition scores.... Thirty-five patients (10 with bilateral CI) experienced 63 unique MES exposure events, 85.7% below and 14.3% above the clavicle. No adverse events or decreased performance due to MES use were reported... No adverse events resulted from MES use in CI patients. Given the increased prevalence and expansion of indications for CIs, and widespread utility of MES, we suggest clarification and improved guidan... 4 Laryngoscope, 133:933-937, 2023....
Predictive Ability of First-Side Cochlear Implant Performance in Adult Sequential Bilateral Cochlear Implantation.
Predictors of second-side cochlear implant performance have not been well studied. We sought to assess whether speech recognition scores from first-side cochlear implant (CI1) could predict second-sid... Retrospective review using a prospectively collected database.... Academic tertiary care hospital.... Fifty-seven adults with postimplantation speech recognition testing performed at least 12 months after CI2.... Sequential bilateral CI.... CI2 performance at ≥12 months as measured using consonant-nucleus-consonant (CNC) words and AzBio sentences in quiet and +10 dB signal-to-noise ratio (S/N).... CI1 performance scores at ≥12 months were independently associated with CI2 performance scores at ≥12 months for CNC words (β = 0.371 [0.136-0.606], p = 0.003), AzBio sentences in quiet (β = 0.614 [0.... CI1 performance is an independent predictor of second-side performance as measured ≥12 months postimplantation. This may be a clinically useful metric when considering adult sequential bilateral impla...
Cochlear implantation programming characteristics and outcomes of cochlear nerve deficiency.
Due to the specificity of cochlear implantation (CI) programming parameters and outcomes in cochlear nerve deficiency (CND) patients, this study aimed to investigate the correlation between programmin... Ninety (95 ears) CND patients (normal cochlea, 39; malformed cochlea, 56) and seventy-nine (81 ears) normal cochlea patients who underwent CI surgery with either Med-El or Cochlear devices were includ... In the CND group, a reduced stimulation rate, higher pulse width, and triphasic pulse were needed in some cases. The stimulus levels of the CND group were significantly higher than that of the normal ... The CI programming parameters of some CND patients need to be adjusted, and a slower stimulation rate and higher pulse width are required sometimes. CND patients need a higher stimulus level than norm...